Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/18408
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBatair, A.-
dc.contributor.authorVan Fraeyenhoven, F.-
dc.contributor.authorVandebroek, A.-
dc.contributor.authorDe Droogh, E.-
dc.contributor.authorGaldermans, D.-
dc.contributor.authorMEBIS, Jeroen-
dc.contributor.authorSchrijvers, D.-
dc.date.accessioned2015-03-19T13:50:52Z-
dc.date.available2015-03-19T13:50:52Z-
dc.date.issued2014-
dc.identifier.citationJournal of Geriatric Oncology, 5 (2), p. 179-184-
dc.identifier.issn1879-4068-
dc.identifier.urihttp://hdl.handle.net/1942/18408-
dc.description.abstractBackground: Screening tools are used in geriatric oncology to determine who should receive a Comprehensive Geriatric Assessment (CGA). However, in this prospective study, we evaluated the association between geriatric screening results, measured with the G8 and Groningen Frailty Indicator (GFI), and severe treatment toxicity. Methods: Patients over 65 years with various types and stages of cancer were screened with the G8 and the GFI prior to the start of treatment. The association between geriatric screening results and Serious Adverse Events (SAE) after the first cycle of (radio) chemotherapy were studied with bivariate analysis (normal versus abnormal screening test) and logistic regression analysis. Results: From 170 screened patients, 85 patients were eligible for this study. The median age was 76 years (range: 66–88 years). The treatment intent was curative in 46% and palliative in 54%. A SAE occurred in 15 patients (18%) of which three resulted in death. There was no significant association between the G8, as a dichotomous predictor (p = 0.376) or as a continuous predictor (p = 0.298), and risk of a SAE. We also found no significant association for the GFI analysed as a dichotomous predictor (cut-off ≥4: p = 0.384; cut-off ≥3: p = 0.773), nor as a continuous predictor (p = 0.734). All associations remained insignificant when adjusted for treatment type and comorbidity. Conclusion: The G8 and the GFI can be used to select patients for CGA, but they do not seem to be predictive for short-term severe treatment toxicity.-
dc.description.sponsorshipThis study was funded by the Belgian Ministry of Health (the National Cancer Plan).-
dc.language.isoen-
dc.rights© 2014 Elsevier Ltd. All rights reserved.-
dc.subject.otherGeriatric screening; G8; Groningen frailty indicator; chemotherapy toxicity-
dc.titleGeriatric screening results and the association with severe treatment toxicity after the first cycle of (radio)chemotherapy-
dc.typeJournal Contribution-
dc.identifier.epage184-
dc.identifier.issue2-
dc.identifier.spage179-
dc.identifier.volume5-
local.bibliographicCitation.jcatA1-
dc.description.notesCorresponding author at: ZNA Middelheim, Lindendreef 1, 2020 Antwerp, Belgium. Tel.: +32 3 280 31 30; fax: +32 3 281 08 00. E-mail address: Abdelbari.Baitar@zna.be (A. Baitar).-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1016/j.jgo.2013.12.004-
dc.identifier.isi000333508600009-
item.fullcitationBatair, A.; Van Fraeyenhoven, F.; Vandebroek, A.; De Droogh, E.; Galdermans, D.; MEBIS, Jeroen & Schrijvers, D. (2014) Geriatric screening results and the association with severe treatment toxicity after the first cycle of (radio)chemotherapy. In: Journal of Geriatric Oncology, 5 (2), p. 179-184.-
item.validationecoom 2016-
item.contributorBatair, A.-
item.contributorVan Fraeyenhoven, F.-
item.contributorVandebroek, A.-
item.contributorDe Droogh, E.-
item.contributorGaldermans, D.-
item.contributorMEBIS, Jeroen-
item.contributorSchrijvers, D.-
item.fulltextWith Fulltext-
item.accessRightsRestricted Access-
crisitem.journal.issn1879-4068-
crisitem.journal.eissn1879-4076-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
1-s2.0-S1879406814000022-main.pdf
  Restricted Access
256.01 kBAdobe PDFView/Open    Request a copy
Show simple item record

SCOPUSTM   
Citations

11
checked on Sep 3, 2020

WEB OF SCIENCETM
Citations

18
checked on Jul 18, 2024

Page view(s)

52
checked on Sep 7, 2022

Download(s)

44
checked on Sep 7, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.